Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MultiVir Inc.
DescriptionHerpes simplex virus-based product candidate genetically engineered to replicate selectively in tumor cells that have defective p16/Rb tumor suppressor gene
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationColorectal cancer
Indication DetailsTreat colorectal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today